除了EP-NEC，维_老虎社区_美港股上老虎

除了EP-NEC，维立志博的LBL-024 在小细胞肺癌、胆道癌等癌种也有初步疗效信号，这意味着适应症扩展空间挺大的，要是后续能在这些大癌种里进一步验证，市场前景可能会更广阔

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":439800924791168,"tweetId":"439800924791168","gmtCreate":1748401375316,"gmtModify":1748402657742,"author":{"id":4090735867032510,"idStr":"4090735867032510","authorId":4090735867032510,"authorIdStr":"4090735867032510","name":"商海观察员","avatar":"https://static.tigerbbs.com/24dad84464b77acef38c400eec091e40","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body>除了EP-NEC，维立志博的LBL-024 在小细胞肺癌、胆道癌等癌种也有初步疗效信号，这意味着适应症扩展空间挺大的，要是后续能在这些大癌种里进一步验证，市场前景可能会更广阔</body></html>","htmlText":"<html><head></head><body>除了EP-NEC，维立志博的LBL-024 在小细胞肺癌、胆道癌等癌种也有初步疗效信号，这意味着适应症扩展空间挺大的，要是后续能在这些大癌种里进一步验证，市场前景可能会更广阔</body></html>","text":"除了EP-NEC，维立志博的LBL-024 在小细胞肺癌、胆道癌等癌种也有初步疗效信号，这意味着适应症扩展空间挺大的，要是后续能在这些大癌种里进一步验证，市场前景可能会更广阔","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/439800924791168","repostId":0,"isVote":1,"tweetType":1,"viewCount":572,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":154,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}